Gynecologic Oncology

Published by: Elsevier Inc.  

People

  1. Kim
    Kim
  2. Abu-Rustum
    Abu-Rustum
  3. Aghajanian
    Aghajanian
  4. Leitao
    Leitao
  5. Park
    Park

Groups

  1. Gynecology Disease Management Team (5)
  2. Surgery (4)
  3. GDMT, Surgery (3)
  4. GME, Surgery (3)
  5. Graduate Medical Education (3)
  6. Department of Medicine (2)
  7. GDMT, Medicine (2)
  8. Gynecologic Medicine Service (2)
  9. Solid Tumor Oncology Division (2)
  10. Department of Pathology and Laboratory Medicine (1)
Search Within
Formats
  1. Journal Article (5)
  2. Meeting Abstract (1)
Groups
  1. Gynecology Disease Management Team (5)
  2. Surgery (4)
  3. GDMT, Surgery (3)
  4. GME, Surgery (3)
  5. Graduate Medical Education (3)
  6. Department of Medicine (2)

More Groups

People
  1. Sarah Kim (3)
  2. Carol Aghajanian (2)
  3. Nadeem Abu-Rustum (2)
  4. Kay Park (1)
  5. Mario Leitao (1)
Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (3)
  4. 2022 (1)
Publishers
  1. Elsevier B.V. (6)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of adding the immune checkpoint inhibitor atezolizumab to first-line chemotherapy on progression-free survival in poor-prognosis ovarian cancer: A retrospective analysis from the IMagyn050 trial
    Journal Article

    You, B.; Anderson, C.; Cecere, S. C.; Carrot, A.; Myers, T.; Heitz, F.; Sharma, S.; Selçukbiricik, F.; Aghajanian, C.; Fernebro, J.; more...
    Gynecologic Oncology (2025)

    Fulltext@MSK | Save
  • The prognosis of stage IA cervical cancer: Subgroup analysis of the SCCAN study
    Journal Article

    Ng, Z. Y.; Manchanda, R.; Lopez, A.; Obermair, A.; Dostalek, L.; Pareja, R.; van Lonkhuijzen, L. R. C. W.; Falconer, H.; Ortiz, D. I.; Fagotti, A.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • PIK3CA and ARID1A mutations in recurrent/metastatic cervical cancer: The NRG Oncology/Gynecologic Oncology Group-0240 National Institutes of Health Beau Biden Cancer Moonshot
    Meeting Abstract

    Hari, A.; Sill, M.; Monk, B.; Birrer, M.; Penson, R.; Lankes, H.; Filiaci, V.; Jones, C.; Reeves, C.; Szot, C.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancer
    Journal Article

    Pignata, S.; Bookman, M.; Sehouli, J.; Miller, A.; Penson, R. T.; Taskiran, C.; Anderson, C.; Hietanen, S.; Myers, T.; Madry, R.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Stratification of lymph node metastases as macrometastases, micrometastases, or isolated tumor cells has no clinical implication in patients with cervical cancer: Subgroup analysis of the SCCAN project
    Journal Article

    Dostálek, L.; Benešová, K.; Klát, J.; Kim, S. H.; Falconer, H.; Kostun, J.; dos Reis, R.; Zapardiel, I.; Landoni, F.; Ortiz, D. I.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Post-recurrence survival in patients with cervical cancer
    Journal Article

    Cibula, D.; Dostálek, L.; Jarkovsky, J.; Mom, C. H.; Lopez, A.; Falconer, H.; Scambia, G.; Ayhan, A.; Kim, S. H.; Isla Ortiz, D.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save

    • Gynecologic Oncology – authorized name for:

    Name ISSN / ISBN Publisher
    Gynecologic Oncology 10956859 Elsevier B.V.